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Abstract
Vitamin  D  is  synthesized  in  the  skin  following  exposure  to  ultraviolet  radiation,
producing cholecalciferol, while only a small percentage of the circulating vitamin D is
of exogenous origin deriving from food. Following two sequential hydroxylations, in
the liver and in the kidneys, vitamin D is fully activated. Although its role in bone
physiology and calcium homeostasis is well documented, there is emerging evidence
that vitamin D exerts a plethora of additional effects on most tissues regulating the
musculoskeletal, cardiovascular, and immune systems as well as energy homeostasis.
Its deficiency/insufficiency poses a major public health problem observed in all age
groups and regardless of latitude and insolation. In muscles, vitamin D deficiency is
associated with  a  decline  in  neuromuscular  function including muscular  strength,
walking speed,  balance,  jumping and sprinting performance,  and aerobic capacity,
although the evidence is still weak regarding its effects in the young and the athletes.
Supplementation counteracts the negative effects of vitamin D deficiency on perform‐
ance although in individuals with adequate levels of vitamin D, additional supplemen‐
tation does not appear to enhance further physical capabilities. The aim of this chapter
is to review our current understanding of diverse effects of vitamin D in physical
performance in athletic and nonathletic populations.
Keywords: vitamin D, Physical activity, athletes, musculoskeletal system, cardiovas‐
cular system, immune system
1. Introduction
Vitamin D is synthesized in the skin from 7‐dehydrocholesterol following exposure to ultra‐
violet radiation (cholecalciferol or D3), and only a small percentage is exogenous originating
from food (ergocalciferol, D2) [1–3]. Following to sequential hydroxylations in the liver and
the kidneys, vitamin D is activated (Figure 1).  Vitamin D plays a crucial role in calcium
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homeostasis in addition to its multiple effects in a plethora of tissues [3]. Indeed, vitamin D
receptors (VDRs) are present in most tissues affecting the transcription of many genes [4–7].
Vitamin D is transported in the blood via vitamin D‐binding protein [8, 9]. Vitamin D plays a
role in the mineralization of type I collagen matrix in the skeleton [10]. Vitamin D and its
nuclear receptor affect the expression of more than one thousand genes acting as a transcrip‐
tion factor [11]. Non‐genomic effects of vitamin D have also been described [12–19].
2. Vitamin D deficiency
A surprisingly high prevalence of vitamin D insufficiency has been recently reported world‐
wide (Table 1) regardless of their insolation [20–23]. In Canada, 30–50 % of children and adults
are vitamin D deficient and need vitamin D supplementation [24]. Similar data have been
reported in Africa, Australia, Brazil, Middle East, Mongolia, and New Zealand documenting
a high risk for vitamin D deficiency in adults and children [24–26]. Cross‐sectional studies of
vitamin D status in adolescents have found deficiency in 17–47 % with an increased risk in
black and Hispanic teenagers [24–26]. It should be noted here that there are fewer reports
regarding the prevalence of vitamin D in athletes. A high prevalence of vitamin D deficiency
has been documented in athletes in both outdoor and indoor sports. For instance, it has been
reported that more than 42 % of distance runners in Baton Rouge, Louisiana, were vitamin D
insufficient or deficient [21]. Indeed, athletes may be more vulnerable to vitamin D deficiency
than age‐matched non‐athletes even in regions with insolation. A recent meta‐analysis pooling
23 studies composed of 2313 athletes found that 56 % of athletes had inadequate vitamin D [23].
In addition, a sizeable number of athletes do not meet the US dietary reference intake for
vitamin D in addition to their inadequate endogenous synthesis when they train indoors [27].
In a recent study, Morton et al. [26] examined the prevalence of seasonal variation in vitamin
D levels in 20 FA Premier League soccer players residing at a latitude of 53°N. Serum 25‐
Figure 1 Biochemical pathways of vitamin D production after exposure to UVB.
A Critical Evaluation of Vitamin D - Basic Overview4
hydroxyvitamin D (25(OH)D) levels decreased in winter to insufficient levels in 65 % of the
soccer players (<50 nmol/L). Koundourakis et al. [28] showed that professional Greek soccer
players’ training at a latitude of 35.9°N had insufficient vitamin D levels, while nearly identical
levels were reported in American national football league players [29], in elite gymnasts in
Australia [30], and in young Hawaiian skateboarders [31] and a variety of other athletes
worldwide [32–35]. These findings were observed irrespective of sun exposure. In a recent
study conducted in Israel in a favorable latitude (31.8°N) for insolation, 73 % of the athletes
were vitamin D deficient. In Qatar, 84 % of soccer players were vitamin D insufficient. Fur‐
thermore, vitamin D deficiency in regions of high sunlight (high insolation) may be due to
clothing, air pollution, and failure to meet the dietary reference intake for vitamin D in addition
to their inadequate endogenous synthesis when they train indoors. Indeed, high prevalence
of low vitamin D levels has been reported in the general population in the United Arab
Emirates, India, and Egypt [36, 37].
Study Population Indoor/
outdoor
Season Country,
latitude
Vitamin D levels
Lovell [30] 18 female gymnasts, age = 13.6
± 1.2 y
Indoor Spring Australia,
35.27°S
Insufficient 83.33 %,
deficient 33.33 %
Constantini et
al. [35]
98 Israeli male and female
athletes and dancers, age = 14.7
± 3.0 y
Outdoor/
indoor
Winter Israel, 31°N Insufficient 73 %,
insufficiency was higher
in dancers (94 %),
basketball players (94 %),
Tae Kwon Do fighters
(67 %), athletes from
indoor sports
Kopeć et al. [32] 24 Caucasian male Polish
professional soccer players
26.24±3.41 y
Outdoor Summer
Winter
Poland,
51.10°N
Cyprus,
30.11°N
Insufficient 37.5 %,
deficient 12.5 %
Insufficient 45.8 %,
deficient 37.5 %
Morton et al. [26] 20 FA Premier League soccer
players
Outdoor/
indoor
Winter United
Kingdom,
53°N
Insufficient 65 %
Galan et al. [40] 28 male soccer players, 26.7
± 3.6 y
Outdoor/
indoor
Winter Spain, 37°N Deficient 64 %
Koundourakis et al.
[28]
67 Caucasian male professional
soccer players, age = 25.6 ± 6.2 y
Outdoor Spring Greece, 35.9°
N
Insufficient 55.22 %
Halliday et al. [34] 93 male athletes (football,
handball, shooting, squash,
cycling, body building, martial
arts), age = 21.3 ± 6.5 y
Outdoor/
indoor
Spring,
summer
Middle East
29°N
Insufficient 91.39 %,
deficient 8.60 %
Willis et al. [33] 19 male and female endurance‐
trained runners, age = 28.3 ± 3.4
y
Outdoor N/A United States,
30°N
Insufficient 42.10 %,
deficient 10.52 %
Close et al. [211] 61 male athletes of soccer,
rugby, jockeys, age = 24.3
± 4.8 y
Outdoor/
indoor
Winter United
Kingdom,
50°N
Deficient 62 %
Close et al. [214] 30 male soccer and rugby
athletes, age = 21.3 ± 1.3 y
Outdoor/
indoor
Winter United
Kingdom,
53°N
Deficient 57 %
Insufficient: vitamin D levels <30 ng/ml [75 nmol/L]; deficient: vitamin D levels < 20 ng/ml [50 nmol/L]; y = years.
Table 1. Vitamin D levels in various athletic populations.
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Generally speaking, vitamin D insufficiency is defined (Table 2) as levels <30 ng/ml (80 nmol/
L), whereas levels below 20 (50 nmol/L) and 10 ng/mL (25 nmol/L) represent deficiency and
severe deficiency, respectively [7]. Levels between 40 and 60 ng/mL are the preferred range,
while vitamin D intoxication usually does not occur until 25(OH)D3 reaches levels higher that
150 ng/ml [24].
Status 25-hydroxyvitamin D (ng/ml) 25-hydroxyvitamin D (nmol/L)
Severe deficiency <10 <25
Deficiency <20 <50
Insufficiency 20–30 50–75
Sufficiency >30 >75
Toxicity >150 >375
Table 2. Classification of vitamin D (25‐hydroxyvitamin D) levels.
3. Seasonal variation of vitamin D levels
Seasonal variation of vitamin D is a well‐documented phenomenon [38]. In the winter months,
endogenous vitamin D production is drastically reduced, as a result of reduced exposure to
UVB radiation, while in summer exposure to UVB radiation is adequate for vitamin D synthesis
by the skin [5]. Similar variations have been reported for athletes. In soccer players, the levels
of 25(OH)D3 are normal in 50 % of the athletes, while this number drops to 16.7 % in winter
[32]. A study performed in a high latitude (Laramie, WY 41.3°N) revealed vitamin D insuffi‐
ciency of 63 % in winter compared to only 12 % in autumn and 20 % in spring in both indoor
and outdoor athletes [38]. Similar findings were reported in a study conducted at higher
latitudes (Ellensburg, WA 46.9°N), using exclusively outdoor athletes. The authors reported
that a percentage of 25–30 % of the athletes were vitamin D insufficient from fall to winter [39].
Morton et al. [26] also reported a significant drop of serum levels of 25(OH)D3 in a group of
professional soccer players of the English Premier League at the latitude of 53°N between
summer and winter. In agreement with these data were findings in professional soccer players
in Spain that have been training at a latitude of 37°N showing a statistically significant
reduction in serum levels of 25(OH)D3 between October and February [40].
Seasonal variation of athletic performance has been found to parallel that of the seasonal
fluctuation of vitamin D levels. Indeed, athletic performance peaks when vitamin D levels are
the highest, i.e., during summer [41]. Koch and Raschka [42] reviewed the German literature
on the seasonality of physical performance. They reported that early studies indicated that
strength and maximal oxygen uptake peaks (VO2max) in late summer. Comparable findings
have been reported by Erikssen and Rodahl [43]. More specifically, in a population of 1835
Norwegian men, physical performance exhibited seasonal variability peaking in summer.
Similar data were reported for the Swedish national track and field teams where VO2max was
observed in summer [44].
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Most authors explain the enhanced athletic performance in summer to the higher vitamin D
levels. However, other authors disagree [41]. According to Moran et al. [26], the higher physical
performance in summer is a consequence of outdoor physical activity in the warmer weather
which also results in exposure of athletes to UAV, i.e., these authors see the two phenomena
as parallel but independent. Athletes participating in athletic events such as track and field
competitions have to be in their best conditioning in the summer since most major competitions
take place at this time period. As a consequence, enhanced training and competition in summer
would result in both better athletic performance and higher vitamin D levels [1, 45]. In contrast,
participants in other sports such as soccer, American football, or basketball attain their best
performance in winter while in summer recuperate resulting in a reduction and/or cessation
of their training and to a deterioration of exercise performance and capacity [28]. Nevertheless,
even when controlling for seasonal fluctuations in time spent exercising, variation in wrist
flexor strength and muscle trainability still correlated with seasonal variations of vitamin
25(OH)D levels [41].
4. Effects of vitamin D in calcium absorption and bone physiology
Vitamin D plays an essential role in calcium homeostasis and the mineralization of bones [46,
47]. In the small intestine, vitamin D augments calcium uptake via an energy‐dependent
transcellular pathway and by a passive paracellular pathway through tight junctions [24, 48].
Insufficient levels of circulating vitamin D cause an increase of serum parathyroid hormone
(PTH) due to secondary hyperparathyroidism, i.e., in a desperate effort of the body to keep
circulating levels of calcium normal borrowing them from bones via an increase of bone
turnover and increased bone resorption [26]. In chronic vitamin D‐deficient states, individuals
are susceptible to osteopenia, osteoporosis, and increased incidence of bone fractures [49, 50].
Administration of vitamin D is recommended as a first‐line strategy reducing the incidence of
osteoporotic fractures [51]. Indeed, low 25(OH)D levels in women could be viewed as a general
marker of impaired health as the Malmö study has documented correlating with increased
overall mortality [52].
Furthermore, low serum vitamin D is associated with cortical bone porosity indicative of
increased bone fragility [53]. Vitamin D also enhances the activity of insulin‐like growth factor
1 (IGF‐1) via an induction the expression of its receptor, an affect crucial in bone formation
both in vitro and in vivo [54].
4.1. Implications of these data on physical activity and exercise performance
Low vitamin D levels are related with osteoporosis and the risk of fractures in elderly indi‐
viduals. Data from cross‐sectional and longitudinal studies report that vitamin D insufficiency
impairs bone health [4, 7]. As a result of this deterioration in bone health, the increased incident
of falls in the elderly can easily result to bone fractures. However, recent evidence indicates
that this is also evident in young physically active individuals. A study on Finish military
recruits reported that those with insufficient vitamin D levels (<30 ng/mL) were susceptible
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with a significant risk of developing stress fracture [55]. Similar findings have been reported
in a number of other studies [56] including athletes [57, 58]. Deterioration in bone strength
could be a problem apart from non‐athletes, also in athletic populations. Hypothetically,
athletes with low bone mineral density are predisposed to skeletal injury especially in contact
individual and/or team sports [4, 7]. The latter could have several implications for the athletic
performance especially in professional athletes. Notably the association between the incident
of fractures and low vitamin D levels in athletes has not yet been determined, and there are
also a number of studies in nonathletic populations that failed to support the hypothesis that
high adequate vitamin D levels protect against stress fractures [4].
5. Effects of vitamin D on the skeletal muscle
The potential association between vitamin D and muscle function was also based on early
clinical descriptions that myopathy was strongly associated with severe vitamin D deficiency
[59]. Currently, vitamin D has been shown to be a potent modulator of skeletal muscle
physiology [5]. Although the expression of the vitamin D receptors in the skeletal muscle tissue
was questioned [60], recent data strongly indicate that they are also expressed in the skeletal
muscle [61]. As we mentioned earlier, 1,25(OH)2D by binding to its nuclear receptor augments
the transcription of key muscular proteins [5–7]. It should be noted here that both genomic
and non‐genomic effects of vitamin D are crucial for muscular performance. Indeed, vitamin
D affects muscular calcium and phosphate transport across cell membranes, phospholipid
metabolism, and muscle cell proliferation and differentiation [62]. In addition, vitamin D
downregulates the expression of myostatin (a negative regulator of muscle mass) and upre‐
gulates the expression of follistatin and insulin‐like growth factor 2 (IGF‐2) [5–7, 63]. Exposure
of skeletal muscles to 1,25‐dihydroxyvitamin D3 induces the expression of several myogenic
markers and transcription factors [63]. A 10‐day incubation of muscle cells with 1,25‐dihy‐
droxyvitamin D3 induces myosin heavy chain (MHC) type II, a late myogenic marker, while
the mean diameter and width of muscular fibers increase compared to parallel controls.
Indeed, vitamin D increases the size of MHC type II‐positive myotubes [61, 64] and the cross‐
sectional area (CSA) of skeletal muscle fibers [65]. Vitamin D signaling has been also reported
to alter the expression of C2C12 myotube size [5, 61], indicating a direct positive effect on the
contractile filaments and thus muscle strength. In addition, it affects the diameter and number
of type II muscle fibers [5–7] and in particular type IIa fibers [61]. In severe vitamin D deficiency,
a proximal myopathy is observed characterized by type II (fast twitch) muscle fiber atrophy
[5, 61]. A recent vitamin D supplementation study showed that in young male populations, a
significant increase in the percentage of type IIa fibers was evident in the vitamin D group
compared to the placebo group, demonstrating a positive effect on the muscle fiber type
morphology, calcium transport, and regulation of intracellular calcium [61].
5.1. Implications of these data on physical activity and exercise performance
The data presented above suggest that vitamin D exerts beneficial effects on skeletal muscles
and thus may improve physical performance capacity in both physically nonathletic individ‐
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uals and athletes. The documented vitamin D‐mediated induction of muscle protein synthesis
and myogenesis could result in muscles of higher quality and quantity. This could be in turn
translated into increased muscle strength since it is well documented that there is a strong
linear associations between muscle mass and strength [66]. In addition the association between
vitamin D levels and muscle anabolism could also be related with another positive effect, which
is particularly important for athletic populations in that it could accelerate muscle recovery
from the stress of intense exercise [26]. This hypothetically could be of major importance in
periods of continues competitions since it could enable them to maintain their performance
capacity at a better level. In the elderly on the other hand, low vitamin D levels could cause a
reduced muscular anabolism, sarcopenia, and thus negatively altered muscle mass which in
turn leads to a negative effects in the sense of balance, strength, and stability. In addition, in
vitamin D‐insufficient states, active individuals may not have adequate energy provisions to
sustain a moderate‐ to high‐intensity muscular effort. Lastly, hypertrophy of type II muscle
fibers could result in enhanced neuromuscular performance [4, 66]. These types of fibers are
a major determinant of the explosive type of human movements resulting in high‐power
output. It is well documented that type II muscle fibers display a markedly faster muscle
contraction velocity and thus higher force than type I muscle fibers [67]. Therefore the
anaerobic maximal‐intensity short‐burst activities, such as jumping, sprinting, acceleration,
deceleration, and change of direction, which are of crucial importance for the majority of the
athletic events, are highly related with the type II muscle fibers. Interestingly, apart from
athletes the importance of type II muscle fibers is highlighted also on the elderly. Reversal of
type II fiber atrophy as a result of vitamin D supplementation is thought to account for
approximately 20 % lower risk of falling [68]. Vitamin D deficiency apart from the atrophy of
type II fibers in these individuals enables fat infiltration and consequently fibrosis (fibrosis is
observed in different tissues including the muscle due to excess fat accumulation) which are
important factors underpinning muscle quality and also may be a predictor of muscle function
in older adult [69]. In closing, based on the available literature, we propose that vitamin D is
beneficial for individuals since it increases muscle protein synthesis, adenosine triphosphate
(ATP) concentration, strength, jump height, jumping and sprinting velocity and power, and
aerobic and anaerobic exercise capacity. Physical performance could be significantly enhanced
and/or preserved with adequate vitamin D. Vitamin D also prevents muscular degeneration
and reverses myalgia [68, 70].
6. Effects of vitamin D on the cardiovascular system
Vitamin D receptors are expressed in human myocardium as well as in vascular smooth
muscles and the endothelium [5, 6]. The activated form of vitamin D, i.e., 1,25(OH)2D,
participates in the structural remodeling of cardiac muscles and vascular tissues [71] and
results in improvements in flow‐mediated dilation and blood pressure [72]. Improved cardiac
muscle function has been reported in patients with severe vitamin D deficiency following
treatment [71]. In addition, animal studies have demonstrated that 1,25(OH)2D directly alters
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myocyte contractility with accelerated relaxation, which is crucial in the normal cardiac
diastolic function [6]. Vitamin D has been also found to regulate the function of calcium
channels in cardiac myocytes, providing a rapid influx of calcium into cells promoting myocyte
contractility [73]. Data from both animal and human studies show that vitamin D can act as a
negative regulator of the renin‐angiotensin‐aldosterone system (RAAS) [6]. It is well docu‐
mented that the RAAS maintains vascular resistance since it is a strong vasoconstrictor agent,
due to angiotensin II synthesis, blood pressure, electrolyte, and intravascular fluid volume
homeostasis. Vitamin D has the ability to decrease RAA activity by suppressing renin gene
expression resulting to the downregulation of the RAA system [6, 45]. This is a vital mechanism
that is regulated by vitamin D since it has been observed that the elevation in renin synthesis
is highly related with left ventricular hypertrophy and the development of hypertension [45].
Another mechanism via which vitamin D insufficiency may induce left ventricular hypertro‐
phy is by affecting and in particular elevating PTH levels. Observational studies have sug‐
gested that apart from hypertension, elevated PHT levels also result to left ventricular
hypertrophy [74]. Vitamin D insufficiency has been found to be related with increased arterial
stiffness and endothelial dysfunction in the conductance and resistance blood vessels in
humans [75, 76]. Vitamin D has also some antiatherogenic functions by promoting HDL
transport and inhibiting cholesterol uptake by the macrophages and the formation of foam
cells [77], while its deficiency stimulates systemic and vascular inflammation, enabling
atherogenesis [78]. In contrast, vitamin D has been shown to suppress inflammation via several
pathways, such as inhibition of prostaglandin and cyclooxygenase pathways, upregulation of
anti‐inflammatory cytokines, decrease of cytokine‐induced expression of adhesion molecules,
reduction of matrix metalloproteinase, and downregulation of the RAA [45].
The presence of vitamin D receptors in the vascular wall suggests that it plays a role in vascular
physiology and pathophysiology [74]. Among individuals with peripheral arterial disease,
low vitamin D status has been associated with a faster decline of functional performance [79].
Severe vitamin D deficiency results in a disrupted adaptive immune response and an inflam‐
matory milieu, promoting vascular dysfunction, insulin resistance, and arteriosclerosis [45, 80].
In addition, recent evidences indicate that severe vitamin D deficiency is strongly associated
with sudden cardiac death [81, 82]. Furthermore, Vitamin D has been found to be a useful
biomarker for the prediction of mortality when obtained at admission for chest pain [83]. The
mechanisms via which vitamin D exert beneficial effects on human myocardium are as follows:
vitamin D inhibits the proliferation of cardiomyoblasts by promoting cell‐cycle arrest and
enhances the formation of cardiomyotubes without inducing apoptosis. Vitamin D also
attenuates left ventricular dysfunction in animal models and humans [84]. However, a group
of researchers were unable to find any association between vitamin levels and risk of cardio‐
vascular disease [85]. It should be noted though that analyzed data from more than 13,000
adults in the Third National Health and Nutrition Examination Survey (NHANES III) found
a strong association between low vitamin D levels and key cardiovascular risk factors (i.e.,
hypertension, diabetes, overweight, and hypertriglyceridemia, but not hypercholesterolemia)
after adjustment for multiple variables [86].
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6.1. Implications of these data on physical activity and exercise performance
As per the available literature presented above, vitamin D plays an important role in the
cardiovascular system [75]. Vitamin D affects several aspects of vascular health, including
arterial stiffness and endothelial function which are crucial components of aerobic and
anaerobic exercise performance and even the ability to perform daily activities. It should be
noted that there is a linear association between vascular health and arterial stiffness to
endurance capacity [80]. In addition, it is well documented that the most accurate measurement
of aerobic capacity, i.e., that of VO2max, is regulated by cardiac output, arterial oxygen content,
shunting of blood to active muscle, and extraction of oxygen by muscles. Since low serum
vitamin D levels may result in pathological myocardial hypertrophy, increased blood pressure,
and endothelial dysfunction [87], these converging lines of evidence could support the idea
that inadequate vitamin D levels could negatively influence cardiorespiratory fitness and the
ability to perform efficiently during exercise. Thus, vitamin D affects aerobic capacity and
VO2max, cardiac output, vascular tone, and supply of oxygen and nutrients to the exercising
muscles.
7. Effects of vitamin D on the nervous system
Vitamin D affects the central and peripheral nervous systems. Vitamin D receptors are present
throughout the brain including the primary motor cortex, the region coordinating movement
[88–91]. Specifically, VDRs have been identified in neuronal and glial cells in several brain areas
including the cortex, deep gray matter, cerebellum, brainstem nuclei, spinal cord, and the
ventricular system [90]. Furthermore, the enzyme 1α‐hydroxylase, the activator of vitamin D
precursors, is also present in the brain [89–93]. Vitamin D levels are associated with the
conductance velocity of motor neurons and neurotransmission mediated by dopamine,
serotonin, acetylcholine, GABA, and the catecholamines [92, 93]. Vitamin D also affects
neuronal differentiation, maturation, and growth, its levels correlating to the levels of several
neurotrophic factors including nerve growth factors (NGF) and that of neurotrophins, which
play crucial roles in the maintenance and growth of neurons [94, 95]. In addition, vitamin D
exerts direct neuroprotective effects via the synthesis of proteins binding calcium (Ca2+) ions
which are important in neuronal function including transmission. Proper levels of neuronal
calcium are critical since their excess may result in the formation of reactive oxygen species
(ROS) which lead to neuronal damage. Indeed, vitamin D levels are inversely associated with
oxidative stress which damages the brain leading to neuronal apoptosis or necrosis [96].
Vitamin D also affects neuroplasticity, a process via which neural synapses and pathways are
adapted to the needs of environmental and behavioral demands adjusting the brain to noxious
stimuli diseases or environmental cues [90, 97, 98]. The VDRs in glial cells play in the uptake
and release of neurotransmitters, including that of GABA neurotransmission within the motor
cortex [99]. GABAergic function is the principal “brake” within the brain affecting muscle
relaxation via the corticospinal neurons [100].
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7.1. Implications of these data on physical activity and exercise performance
The data described above suggest that vitamin D exerts major effects on several aspects of brain
function. The effects of vitamin D on GABAergic tone and on serotonin and dopamine are
crucial for muscular coordination and avoidance of central fatigue, a condition associated with
the synaptic concentration of several neurotransmitters [101]. A high ratio of serotonin to
dopamine affects exercise performance because of its effect on the general feeling of tiredness
and the perceptions of effort [102].
Another mechanism via which vitamin D affects the brain and athletic performance may
involve the nocireceptors or nociceptors, i.e., the sensory nerve cell that responds to noxious
stimuli by sending signals to the spinal cord and brain. The nociceptors are replete in VDRs
and 1α‐hydroxylase [103, 104]. When these receptors transfer pain signals to the brain, an
inhibitory physical response takes place [104]. The relevance of this mechanism and vitamin
D and physical activity/performance is based on the recent findings in animal studies that
vitamin D depletion could result in nociceptive hyperinnervation and hypersensitivity within
deep muscle tissue and a loss of balance without affecting muscle strength or the cutaneous
nociceptive response [103]. Based on this finding, we could speculate that nociceptive hyper‐
innervation and hypersensitivity within deep muscle tissue could result to a false onset of
myalgia during physical activity which in vitamin D‐deficient individuals could result to a
reduction in performance. The beneficial effects of vitamin D‐mediated effects of the nervous
system on physical activity and exercise performance are further supported by the findings of
Dhesi et al. [105]. Reaction times deteriorate with age [105] and play an important role in
neuroprotective responses [106]. In cross‐sectional work, we identified a correlation between
vitamin D status and reaction times, suggesting a neuroprotective role of this vitamin [105].
However, it is still unknown whether the latter mechanisms could be attributed also to young
healthy individuals or athletic population.
8. Effects of vitamin D on pulmonary function
Vitamin D affects pulmonary function and health. Vitamin D insufficiency has been associated
with impaired pulmonary function, asthma, and chronic obstructive pulmonary disease
(COPD) [107, 108]. It should be noted that vitamin D deficiency may harm the lungs not only
via its well‐known immune effects. The Third National Health and Nutrition Examination
Survey (NHANES III) reported a strong positive association between serum 25(OH)D and
forced expiratory volume (FEV1) and forced vital capacity (FVC). These effects of vitamin D
may be mediated through surfactant, a substance maintaining alveolar structural integrity
[109], lung compliance, and oxygen exchange. It should be stressed that lung compliance,
FEV1, FVC, and cardiopulmonary oxygen transfer are linearly related with physical perform‐
ance [110]. Indeed, vitamin D induces the synthesis of alveolar surfactant and plays a critical
role in epithelial‐mesenchymal interactions during lung growth [111]. Vitamin D plays a role
in COPD and more specifically in smooth muscle proliferation in the airways [112, 113]. Zosky
et al. [114] have provided evidence supporting a direct role of vitamin D on lung growth in
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vivo, while vitamin D deficiency results in lung volume deficits [115]. Finally, vitamin D
insufficiency correlates with multiple indices of compromised lung function and increased
airway reactivity [115].
8.1. Implication of these data on physical activity and exercise performance
The data described above provide evidence implicating vitamin D in alveolar structural
integrity, lung compliance, vital capacity, cardiopulmonary oxygen transfer, airway smooth
muscle proliferation, and lung remodeling. Regarding athletes, exercise performance and
aerobic capacity (VO2max) depend on all these lung functions [28]. Adequate VO2max levels are
needed in all sporting disciplines. Vitamin D appears to affect all components of VO2max
adequacy.
9. Effects of vitamin D on immunity
Vitamin D affects the innate and adaptive immunity via VDRs [116–118]. Vitamin D enhances
monocyte/macrophage activity. Vitamin D directly activates the transcription of several
antimicrobial substances including defensin β2 (DEFB) and cathelicidin [118, 119]. Human
cathelicidin (hCAP18) causes destabilization of microbial membranes [120]. In college athletes
vitamin D insufficiency is associated with higher frequency of illnesses including common
colds, influenza, and gastroenteritis [27]. Furthermore, vitamin D affects both T and B cells
[121]. Under resting conditions the expressions of VDRs are low in both T and B cells, but they
are upregulated in infectious diseases, suggesting a crucial role in adaptive immunity [122–
125]. Indeed, vitamin D affects B‐cell function, including inhibition of memory‐ and plasma‐
cell generation and apoptosis.
It is also known for years that immune cells can activate vitamin D to 1,25(OH)2D via 1α‐
hydroxylase, an effect resulting in several beneficial paracrine effects including modulation of
T‐cell function [126]. Vitamin D upregulates the expression of several antimicrobial peptides
(AMP) while at the same time downregulates the expression of inflammatory cytokines
including that of tumor necrosis factor α (TNFα) and interleukin (IL) 6 [126]. Low levels of
vitamin D in the general population and in athletes (especially following intense exercise)
result in IL6 and TNFα increase. Vitamin D ameliorates this inflammatory response.
Several studies have also documented a negative association between vitamin D levels and
upper respiratory tract infections (URTIs) in young and elderly adults [127–129]. In athletes,
the incidence of respiratory illnesses is higher (especially at the elite level) because of the high
dements on the lungs during prolonged exercise [130]. This could lead to increased exposure
to viral and bacterial pathogens from the external environment, increasing the risk of URTIs.
Li and Gleeson [131] have suggested that low vitamin D levels may exaggerate the vulnera‐
bility of athletes to URTIs, while individuals with higher vitamin D levels exhibit a lower
propensity to URTI [132, 133]. It has been suggested that vitamin D prevents the development
of URTIs by affecting the activation of toll‐like receptors (TLRs) [134]. Vitamin D interferes
with the activation of TLR signaling by microbial antigens via cathelicidin and β‐defensin
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[134]. Cathelicidin enhances the microbicidal capability of monocytes/macrophages by
increasing the oxidative burst of these phagocytic cells, an effect also depended on vitamin D
[134].
9.1. Implications of these data on physical activity and exercise performance
It is reasonable to suggest that the well‐documented association between optimal vitamin D
levels and the well‐being and the proper function of the immune system combined with the
anti‐inflammatory effects of this vitamin D may improve athletic performance. The observation
that low vitamin D levels may result in increased pro‐inflammatory cytokine levels, such as
TNFα and IL6, following periods of intense exercise training may suggest that this pro‐
inflammatory period may be ameliorated by vitamin D [68]. This effect may accelerate the
recovery phase from the stress of intense exercise. High IL6 and TNFα levels may partially
explain age‐related skeletal and muscular failings in vitamin D‐deficient older individuals.
Reduction of TNFα levels following vitamin D supplementation may be crucial to combat the
“overtraining syndrome” in athletes [135]. Furthermore, the cytokines IL‐10 and IL‐13 have
been shown to promote muscle regeneration and prevent skeletal muscle damage [136, 137].
Regarding the effects of vitamin D on the URTIs, its negative association with URTIs has been
addressed by He et al. [138] who reported a higher proportion of subjects who experienced
one or more URTI episodes in the vitamin D‐deficient state during the 4‐month study period
than the optimal vitamin D group [138]. In closing, since vitamin D has been shown to affect
the inflammatory response and prevent URTIs, its use may be of practical significance in the
athletes.
10. Effects of vitamin D on the adipose tissue
Vitamin D plays a crucial role in the physiology of adipocytes. VDRs and the 25‐hydroxyvi‐
tamin D 1α‐hydroxylase (CYP27B1) genes are all expressed in human adipocytes [139].
Vitamin D levels are inversely related to obesity including body fat percentage (BFP), body
mass index (BMI), and waist circumference [140, 141]. Vitamin D supplementation for 16 weeks
reduces visceral fat in overweight and obese adults [142]. Drincic et al. [143] identified body
weight as the single strongest predictor of 25OHD levels followed by fat mass. The loss of
weight results in an elevation of vitamin D levels [144]. Epidemiologically, vitamin D levels
are negatively associated with BFP in non‐athletes [19, 145, 146]. Interestingly, a high BFP in
winter months has been found correlating with indoor athletic activities and low vitamin D
levels [146].
10.1. Implications for physical activity/exercise performance
The close association between vitamin D levels and adiposity could affect athletic performance.
It should be noted that neuromuscular performance capacity including sprinting ability,
jumping performance, agility, acceleration, aerobic capacity, and deceleration is inversely
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associated with BFP [147]. These data suggest that high BFP in conjunction with low vitamin
D levels exerts a detrimental effect on exercise performance in athletes as well as in the general
population. It should be noted that increased BFP is associated with the development of a
systemic chronic low‐grade inflammation and insulin resistance, a characteristic of obesity,
which also negatively affect exercise performance [148].
11. Effects of vitamin D on the electron transport system
Vitamin D has been also suggested to be related with the production of adenosine triphosphate
(ATP) via the aerobic pathway. In particular, this speculation has been based on the observa‐
tions that vitamin D appears to affect electron transport. Vitamin D receptors are present
within mitochondria. Silencing of vitamin D receptors in several cell lines results in growth
inhibition accompanied by an increase in mitochondrial membrane potential sensitizing cells
to oxidative stress [149]. Vitamin D plays a role on mitochondrial respiratory chain activity
acting as a facilitator of the diversion of acetyl‐CoA from the energy‐producing TCA cycle
toward biosynthetic pathways that are essential for cellular proliferation. These effects of
vitamin D on aerobic energy production during exercise are needless to say crucial for exercise
performance.
12. Insolation and vitamin D on athletic performance
Early studies on collegiate athletes and students showed that cardiovascular fitness, muscle
endurance, and speed were enhanced following exposure to ultraviolet radiation [150–152].
In particular, in 1938 Russian authors [151] reported that a course of ultraviolet irradiation
improved speed in the 100 m dash in four students compared with matched controls. The
authors observed that the experimental group (i.e., under UAV treatment) had a 7.4 % increase
in 100 m dash times compared to only 1.7 % of the control group. Notably both groups were
undergoing the same training schedule throughout the study. Supportive evidence came from
a study by German researchers in 1944 [152]. A treatment under UV irradiation twice a week
for a period of 6 weeks resulted in a 13 % improvement in performance on a bike ergometer.
No alteration was evident in the control group. Enhanced performance parameters were also
reported by Allen and Cureton [150] as a result to UAV treatment in college students. The
authors observed that a period of 10 weeks under UV treatment resulted in improvements in
both cardiovascular fitness and muscular endurance. UV increased cardiovascular fitness by
19.2 % compared to only 1.5 % improvement in the controls. In 1956, Sigmund [153] examined
the effects of UV radiation on reaction times on adolescents and adult individuals. UV
treatment improved by 17 % the reaction time compared to controls. In another study in the
late 1960s, a single dose of UV irradiation beneficially affected the strength, speed, and
endurance of college women [154]. Interestingly, the beneficial effect was evident in white
participants but not in African American females, suggesting a different skin response to UV.
A follow‐up study from the same team [155] observed that the same amount of UV managed
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to improve aerobic performance in the same population. Enhanced performance was also
observed by another study in a 30‐yard dash of 15 college women after 6‐minute exposure in
UV light [156].
13. Vitamin D deficiency in athletes versus non-athletes
It is increasingly apparent that athletes need higher levels of vitamin D because of the higher
demands of the daily strenuous training exercise which they undergo [157]. Indeed, experi‐
mental findings suggest a major role of vitamin D in muscle mass, strength, and function.
Vitamin D affects significantly the athletic ergometrics [158]. Furthermore, athletic perform‐
ance appears to show a seasonal variability peaking when vitamin D levels peak and declining
as they decline reaching nadir when vitamin D levels are at their lowest. It should be noted
that vitamin D administration improves athletic performance in vitamin D‐deficient athletes
[41].
14. Vitamin D in non-athletes
Overwhelming evidence demonstrates the association between vitamin D levels and the ability
of non‐athletes to perform their daily physical activities and/or exercise (Table 3). Early on,
myopathy and muscle weakness were attributed to the most obvious consequence of vitamin
D deficiency, i.e., that of rickets and osteomalacia [159]. To date, several cross‐sectional
observations and longitudinal studies have reported a close association between vitamin D
and several parameters of physical performance. The majority of the studies have been
performed on elderly subjects although similar data have been reported in adults below the
age of 65 years [160] and in young individuals [161, 162].
Author Participants Physical performance parameters
tested
Results
Ward et al.
[161]
99 adolescent girls, 12–14
y
Jump power, countermovement
jump(CMJ) height, and velocity,
Esslinger Fitness Index, force
Positive relationship between vitamin D
levels and jump velocity, jump height,
power, Esslinger Fitness Index, and
force
Foo et al.
[162]
301 healthy Chinese
adolescent girls, age 15.0
± 04 y
Handgrip strength, physical
activity levels
Adequate vitamin D status had greater
handgrip muscle strength than deficient
Gerdhem et
al. 155
1044 elderly women, 75 y
old (range 75.0–75.9
y old)
30 m gait, knee extension, knee
flexion, Romberg balance, self‐
estimated activity level
Positive relationship between vitamin D
levels and gait speed, Romberg balance
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Author Participants Physical performance parameters
tested
Results
test, self‐estimated activity level, and
thigh muscle strength
Houston et
al. [166]
988 elderly males and
females, age 85.2 ± 3.6 y
SPPB test (standing balance,
repeated chair stands, 3 m walk
[gait speed]), grip and knee
extensor strength
Significantly poorer SPPB in deficient
individuals versus those in sufficient
state. No relationship between vitamin
D levels and absolute grip and knee
extensor strength. Older adults with
deficient 25(OH)D levels had
significantly lower muscle strength
indicating poorer muscle quality
Visser et al.
[167]
1260 elderly males and
females >65 y old
Physical activity (30, 30–59, or 60
min/day), timed walking test, and
a repeated chair stand test
Vitamin D‐deficient and vitamin D‐
insufficient individuals had poorer
physical performance in all tests
Bischoff‐
Ferrari et al.
[168]
4100 elderly males and
females >60 y old
8‐foot walk test and sit‐to‐stand
test
Vitamin D levels between 40 and
94 nmol/L were associated with better
musculoskeletal function in the lower
extremities than concentrations of
40 nmol/L. Significant positive
association between vitamin D levels
and the 8‐foot walk test, the sit‐to‐stand
test
Tieland et al.
[169]
127 pre‐frail and frail
elderly people, ≥65 y old
Short physical performance battery
(SPPB) test, maximum strength
(one repetition maximum)
Significant positive associations were
observed between vitamin D levels and
gait speed and chair rise
Houston et al.
[174]
1155 elderly individuals,
aged 65–102 y old
Short physical performance battery
(SPPB), handgrip strength
Significant positive associations were
observed between vitamin D levels and
SPPB score in men and handgrip
strength in men and women
Wicherts et
al. [177]
1234 elderly men and
women, age 79.8 ± 5.9 y
Time taken to walk 3 m, turn 180°,
and walk back (walking test); time
taken to rise five times from a
kitchen chair with arms folded in
front of the chest (chair stands); the
ability to stand with the heel of the
one foot directly in front of, and
touching the toes of, the other foot
for at least 10 s (tandem stand)
Vitamin D levels were associated with
physical performance which was poorer
in participants with levels < 10 ng/ml
and levels of 10–20 ng/ml
Mastaglia et
al. [178]
44 postmenopausal
women, age 71 ± 4 y
Walking‐speed test, standing
balance, and sit‐to‐stand tests.
Women with vitamin D levels ≥ 20 ng/ml
scored higher on the muscle function
Vitamin D and Physical Activity
http://dx.doi.org/10.5772/65103
17
Author Participants Physical performance parameters
tested
Results
Lower extremity muscle strength
was determined using a manual
dynamometer
tests and had stronger knee extensor
and hip abductor muscles
Ceglia et al.
[181]
1219 males, age 4.9 ± 12.8
y
Timed walking test, chair stand
test, grip strength
No association was evident between any
physical performance test and vitamin D
levels
Matheï et al.
[182]
367 elderly males and
females, age 84.7 ± 3.6 y
old
Balance, grip strength, and gait
speed
No significant relation between vitamin
D levels and balance, gait speed and
grip strength, and serum
y, years
Table 3. Vitamin D levels and physical performance in non‐athletes.
In the elderly vitamin D deficiency has been associated with myopathy, reduced muscle mass
and strength, low exercise performance, and an increased risk of falling [163]. The rise of
vitamin D levels has been associated to improved balance [164], reduced frailty and disability
[165, 166], independence [167], and better mobility [168, 169]. Improved balance and mobility
independent of muscle function may partly explain the association of vitamin D with the
reduced risk of falls in older adults. It is well documented that the maintenance of muscle
strength and power in this population is also related with the ability to perform all types of
physical activities and therefore well‐being and functional performance. In the elderly,
mobility limitations have been defined as the self‐reported inability to walk a mile, climb stairs,
or perform heavy housework [170]. This is dependent on multiple components such as
muscles, bones, and the cardiovascular system, and vitamin D has been found to play a crucial
role in the functionality of these tissues. The impairment in any of these tissues could lead to
reduced mobility that in turn could cause accelerated functional decline and disability. Given
that both muscle strength and power are related to the functional activities in older adults [161,
171], it could be argued that assessing the potential parameters that could affect muscle
strength or power and even muscle quality would identify ways to avoid impaired mobility
and functional performance. In addition, proper cardiovascular function is essential to perform
adequately all types of activities. In this context, it could be suggested that vitamin D is
involved in the regulation of strength and power (as a product of strength) and affects the
proper cardiovascular function and also the quality of the muscles (fat infiltration in vitamin
D‐deficient state). The latter is related with vitamin D since in the deficient state, it has been
reported that there is increased fat infiltration in the muscle. This physiological mechanism is
associated with lower levels of muscle strength and physical performance, independent of
muscle mass [172]. To date, a number of organizations recognize that vitamin D is directly
related with the falls in the elderly, including the International Osteoporosis Foundation, the
Endocrine Society, and the US Preventive Services Task Force [173]. In accordance are the
observations of Gerdhem et al. [164]. The authors evaluated the association between 25‐
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hydroxyvitamin D levels (25OHD), fall‐associated variables (including tests of functional
performance), and fracture in ambulatory women. A low 25OHD was associated with lower
physical activity, gait speed, and balance. Vitamin D levels below 20 ng/ml have been associ‐
ated with an increased risk of fractures. It has been suggested that the minimum level of
25OHD required to maximize the reduction of falls and fractures appears to be in the order of
60 nmol/L. Any increases above this do not appear to have any additional beneficial effect in
lowering the risk of falling [173].
Regarding physical performance per se, several cross‐sectional studies indicate a positive
association between physical performance and serum vitamin D in the elderly. In the In‐
CHIANTI study, a representative sample of 976 persons aged 65 years or older at study baseline
was examined [174]. Physical performance was assessed. A significant association between
low levels of vitamin D and poor physical performance as assessed by the handgrip strength
test and a short physical performance battery (SPPB) test (which included ability to stand from
a chair and ability to maintain balance in progressively more challenging positions) was
documented. It was found that individuals with serum vitamin D levels < 25 nmol/L performed
worse than those with levels above 25 nmol/L. Muscle strength using a handgrip test was also
significantly greater in subjects with vitamin D levels higher than 50 nmol/L than those with
lower levels [174]. The use of grip strength as a tool is relatively straightforward to stratify
adults at risk of impaired mobility. It has been shown in elderly individuals that higher levels
of vitamin D correlated with better lower extremity muscle performance compared to age‐
matched individuals with lower levels [169]. Similar data have been shown in the Rancho
Bernardo Study cohort [175]. Likewise in a longitudinal survey of community‐dwelling
Japanese, older women showed that those with higher levels of vitamin D responded better in
a 3‐month exercise program than those with lower vitamin D levels [176].
Wicherts et al. [177] examined the association of serum 25‐hydroxyvitamin D levels to physical
performance and its decline with age. The authors reported that after adjustment for age,
gender, chronic diseases, degree of urbanization, body mass index, and alcohol consumption,
a relationship was evident between vitamin D levels and physical performance indices.
Physical performance was inferior in individuals with low vitamin D compared to age‐
matched individuals with serum 25OHD levels higher than 30 ng/ml. Thus 25OHD levels
below 20 ng/ml appear to be associated with poorer physical performance and a greater decline
in physical performance in older men and women.
In another study on elderly females aged over 65 years, the authors examined the association
between vitamin D levels and muscle function and strength. Performance was evaluated by a
walking‐speed test, standing balance, and a sit‐to‐stand test [178]. It was observed that vitamin
D levels above 50 nmol/L were related with higher levels of muscle strength. The authors also
reported that the individuals with the lowest 25OHD levels (i.e., below 20 nmol/L) had the
poorest values in strength. Stockton et al. [179], based on the observations from their meta‐
analysis, concluded that vitamin D had no significant effect on lower extremity muscle strength
except in individuals with starting serum 25OHD levels <25 nmol/L. In support to this
suggestion are the findings of Pramyothin et al. [180]. In a study performed in older Hawaiian
women of Japanese ancestry, which are known for its very low rate of falls, a high dietary intake
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in vitamin D, and a large exposure to sunlight, their mean vitamin D level was 80 nmol/L,
while no individuals were in a vitamin D‐deficient state. The authors failed to observe any
association between vitamin D levels and all the measured performance parameters, i.e.,
physical strength test (except for the quadriceps), falls, and daily activities. It was concluded
that the absence of a relationship was due to the very high level of vitamin D that these women
had at baseline. Mastaglia et al. [178] suggest that there is a limit below which vitamin D
insufficiency may affect physical performance. In agreement to this hypothesis are the findings
of a recent study [181]. The authors reported that in a population‐based sample of adult men
with a broad age range (mean age is 47 years), there was no association between serum
25(OH)D concentration and lean body mass, muscle strength, and physical function after
controlling for multiple lifestyle factors. However, only 20 % of the subjects had a vitamin D
level below 50 nmol/L. This observation is giving further support to the cause‐effect hypotheses
of “sufficient” or “insufficient” vitamin D levels on several indices on human physiology
including physical function and athletic performance. However confusing findings have been
reported by Matheï et al. [182] in elderly individuals (>80 years) with an 80 % prevalence of
vitamin D insufficiency where no correlation was evident between vitamin D levels and
physical performance, as assessed by gait speed, handgrip test, and a static balance test. The
authors suggest that this absence of association could be at least partly due to age‐related
downregulation of the VDR in muscles [182]. On the other hand, Ward et al. [161] reported
that in vitamin D‐insufficient young adolescent girls, there was a correlation between vitamin
D levels and muscle power, force, velocity, and jump height. Similarly, Foo et al. [162] found a
positive association between vitamin D serum levels and handgrip strength in a population of
301 vitamin D‐sufficient adolescent girls. However, studies in young women failed to verify
any association between vitamin D status and muscle performance, handgrip strength [183],
or any other physical performance parameter [184]. These discrepancies may be partially
explained by differences in the experimental protocols, accuracy of vitamin D serum meas‐
urements, age of the participants, muscle fitness, health state, gender, and other variables. In
summary, most published data suggest an association of vitamin D levels greater than 50 nmol/
L with muscle fitness. Vitamin D‐associated improvement of balance and mobility are
independent variables form muscle function and may partially explain the beneficial effect of
vitamin D supplementation on the rate of falls in older individuals [185].
15. Vitamin supplementation in non-athletes
Vitamin D levels in the blood are increasingly recognized as an important factor in muscular
well‐being and functional performance. As a consequence, it was speculated that vitamin D3
supplementation may exert beneficial effects on physical activity. Indeed, several major trials
have demonstrated that vitamin D supplementation lower the risk of falling (Table 4). Prince
et al. [186] in a randomized, controlled trial in Australia evaluated women with at least one
fall in a 12‐month period and with a plasma 25‐hydroxyvitamin D level <24.0 ng/mL. The
authors suggested that elderly with a history of falling and vitamin D insufficiency living in
sunny climates benefit from ergocalciferol supplementation resulting in a 19 % reduction in
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the relative risk of falling, mostly in winter. Pfeifer et al. [187] demonstrated a reduction in falls
of 27–39 % in community‐dwelling seniors supplemented with 800 IU vitamin D and calcium
daily versus calcium alone. This drop in falls was correlated with an improvement in quadri‐
ceps strength and in the timed up and go (TUG) test. Similarly, Zhu et al. [188] reported an
enhanced muscular strength and TUG test in the individuals within the lowest vitamin D
quartile. These results are consistent with another study that showed a 49 % reduction of falls
in elderly women from a geriatric ward supplemented with 800 IU per day of vitamin D [189].
Bischoff‐Ferrari et al. [189] evaluated several studies involving men and women with an
average age of 70 that vitamin D supplementation resulted in a significant 22 % decrease in
fall risk.
Study Quality Participants Intervention Parameters measured Results
Prince et
al. [186]
Double‐blind,
randomized
controlled
trial
302 community
‐dwelling
ambulant older
women, aged
70–90 y old
1000 mg/day of
calcium for 1 year
combined with 1000
IU/day of
ergocalciferol or
identical
Risk of falling Ergocalciferol
supplementation
resulted in a 19 %
reduction in the relative
risk of falling
Zhu et al.
[188]
Randomized
controlled
trial
302 community
‐dwelling
ambulant
elderly women;
mean age:
76.9 ± 4.5 y
1000 IU/day of
vitamin D2 or
identical placebo;
calcium citrate (1 g
calcium/day) in both
groups
for 1 y
Timed up and go (TUG)
test, ankle dorsiflexion,
knee flexor, knee extensor,
hip abductor, hip flexor, hip
extensor, and hip
adductor strength were
assessed
Significant ↑ in knee
flexor strength and all
hip muscle strength and
TUG in both groups.
Ankle dorsiflexion
strength significantly↓ in
both groups, no change
in knee extensor
strength after 12 months
Bunout
et al.
[191]
Randomized
double‐blind
controlled
trial
96 healthy
elderly subjects
aged > 70 y
Participants were
randomized to a
resistance training or
control group. Trained
and control groups
were further
randomized to receive
vitamin D 400 IU plus
800 mg of calcium per
day or calcium alone
for 9 months
Handgrip strength,
Isometric quadriceps
maximum voluntary
strength, endurance,
general physical fitness,
measuring the timed up
and go (TUG), short
physical performance
battery (SPPB)
Timed up and go ↑ more
in trained subjects
supplemented with
vitamin D. At the end of
the follow‐up, gait
speed was ↑ among
subjects supplemented
with vitamin D (whether
trained or not)
Bischoff
et al.
Randomized
double‐blind
controlled
122 elderly
women, mean
age = 85.15 ±
Calcium 1200 mg and
800 IU/day vitamin D
TUG test, grip a strength,
knee flexor strength, knee
↓Risk of falls and in 62
women with complete
for all strength test,
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Study Quality Participants Intervention Parameters measured Results
[192] trial 6.8 y versus calcium 1200
mg/day for 12 weeks
extensor strength, risk of
falls
there was significant ↑ in
all measured parameters
Moreira‐
Pfrimer
et al.
[193]
Randomized
double‐blind
controlled
trial
46 individuals
(11 males and
35 females), age
= 77.6 8 ± 8.2 y
6‐month period: daily
calcium + monthly
placebo or daily
calcium + oral
cholecalciferol (150,000
IU once/month the first
2 months, 90,000 IU
once/month until the
end)
Maximum isometric
strength of hip flexors
(SHF) and knee extensors
(SKE)
SHF ↑ in the calcium/
vitamin D group by 16.4 
% and SKE ↑ by 24.6 %
Pfeifer et
al. [194]
Randomized
double‐blind
controlled
trial
242 community
‐dwelling
elderly women
and men, mean
age 77 ± 4 y
1000 mg of Ca or
1000 mg of Ca plus
800 IU of vitamin D
per day for 12 months,
followed by an 8‐
month treatment‐free
observation period
Timed up and go (TUG)
test, maximum isometric
leg extensor strength
Vitamin D resulted in a
significant ↓ falls of 27 %
at month 12 and 39 % at
month 20 and in
significant ↑ and ↓in
quadriceps strength and
time to perform the TUG
test, respectively
Janssen
et al.
[196]
Randomized
double‐blind
placebo‐
controlled
trial
70 female
geriatric
patients >65 y
old
400 IU/day of
cholecalciferol + 500
mg/day of Ca or a
placebo +500 mg/day
of Ca for 6 months
Handgrip strength, leg
extension power, get up
and go (GUT) test,
modified Cooper test
No significant
improvements in
strength and physical
activity measures
Brunner
et al.
[197]
Randomized,
double‐blind,
placebo‐
controlled
trial
33,067 women
aged 50–79 y
old
1000 mg calcium
carbonate plus 400 IU
vitamin D‐3 or
matching placebo in a
regimen of two pills
per day
Grip strength, chair stand
test, timed walk test,
physical activity status,
physical function (self‐
report), physical activity
(self‐report)
No evidence of
treatment effects on
measures of any kind of
physical functioning,
activity, and strength
were observed
Gupta et
al. [200]
Randomized,
double‐blind,
placebo‐
controlled
trial
40 healthy
males and
females, age
31.5 ± 5.0 y
60,000 IU of vitamin
D3/w for 8 weeks
followed by 60,000
IU/m for 4 months
with 1 g of Ca daily or
dual placebos for 6
months
Handgrip and gastro‐
soleus dynamometry,
pinch‐grip strength,
respiratory pressures,
6 min walk test
All measured physical
performance parameters
↑ significantly in the
treatment group
A Critical Evaluation of Vitamin D - Basic Overview22
Study Quality Participants Intervention Parameters measured Results
Owens et
al. [201]
Placebo‐
controlled
trial
29 male
participants,
mean age =
22.7 ± 3 y
Oral dose of 10,000
IU/day vitamin D3 or
a visually identical
placebo for 3 months
Lower limb muscle
function, isokinetic torque,
percutaneous isometric
electromyostimulation
No significant changes
in any of the measured
performance indices
y, years; ↑, increase; ↓, decrease
Table 4. Vitamin supplementation in nonathletic population.
Recent studies on elderly populations support the data regarding the beneficial effect of
vitamin D supplementation on neuromuscular performance improving strength [9] and
force production [190]. Furthermore, a significant linear association between vitamin D levels
and muscular strength, body sway, and physical performance is evident [106, 191, 192]. In
addition, Moreira‐Pfrimer et al. [193] reported that vitamin D supplementation results in
improved isometric muscle strength following a 6‐month supplementation of daily cholecal‐
ciferol resulting in an increase of strength of hip flexors (SHF) and strength of knee exten‐
sors (SKE).
In addition to the strength of lower extremities, upper extremity strength also benefits from
vitamin D supplementation. However, regarding grip strength, a tool that is relatively
straightforward to stratify adults at risk of impaired mobility, the results are confusing. In a
recent review of the literature, it was reported that grip strength does not seem to respond to
vitamin D supplementation in males [194]. The failure to observe any association between grip
strength in the male population is in agreement with others. Effects of vitamin D treatment on
handgrip strength have been evaluated in several studies, none of them showing significant
effects in contrast to women [191, 194–197]. This could be related with the gender of the
participants in the studies. A recent research suggests that there are gender differences in the
vitamin D that affect functional performance [198].
In an attempt to examine the effects of vitamin D supplementation concomitantly with
resistance training, Agergaard et al. [61] performed a study in young and elderly untrained
males. The participants of this study were randomized to a daily supplementation of vitamin
D plus calcium or just calcium for a period of 16 weeks. The study took place during a period
and at latitude of low sunlight (December–April, 56°N). All individuals followed a progressive
resistance training program of the quadriceps muscle during the last 12 weeks of the study.
Measurements of muscle hypertrophy (defined as changes in CSA) and quadriceps isometric
strength levels were performed. Muscle biopsies were analyzed for fiber type morphology,
expression of VDR, and Myostatin [61]. The authors failed to observe any difference between
the groups in quadriceps CSA and isometric strength despite the observed increase in strength
that was evident in both groups compared to baseline. Vitamin D intake and strength training
increased both strength and CSA in elderly individuals compared to the young group. In the
young vitamin D group, the authors observed that the experimental period resulted in an
increase in fiber type IIa percentage and a lower Myostatin mRNA expression compared to
the control group. No additive effect of vitamin D intake during 12 weeks of resistance training
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could be detected on either whole muscle hypertrophy or muscle strength. The authors
attributed this lack of response to vitamin D supplementation to the fact that the participants
in their study were vitamin D sufficient, compared to the findings of studies that have observed
enhanced performance to vitamin D supplementation that have employed individuals in a
deficient state [191–193, 196, 199, 200]. They suggest that the muscular performance benefits
may be relevant only for individuals with vitamin D deficiency. However, a recent study using
insufficient young males failed to report improvements to performance via vitamin D treat‐
ment [201]. The authors observed that despite the elevation in vitamin D levels (>120 nmol/L),
no effect was observed in performance parameters (muscle strength evaluated by isokinetic
dynamometry and percutaneous isometric electromyostimulation). The latter study suggests
that other parameters apart from vitamin D levels are responsible for the effect on performance
such as age, type of vitamin D that was given, period of supplementation, and amount of
supplementation.
A recent review of the literature which included controlled and randomized controlled trials
that have measured muscle strength and serum vitamin concentration in 18–40‐year‐old
participants reported that the outcome of the available evidence is that vitamin D supplemen‐
tation increases upper and lower limb strength in young and healthy individuals [200, 200,
202]. However, this increase seems to be dependent on the supplementation treatment
employed. According to Tomlinson et al. [202], studies that have reported individual signifi‐
cant increases in muscle strength employed a total dosage of between 60,000 and 14,000 IU
vitamin D/week over 6–4 months. Another study prescribed a daily dose of 2000 IU vitamin
D as per previously published systematic reviews which suggested that daily dosages are more
beneficial than larger, staggered doses. However, adding to the contradiction, Gupta et al.
[200], who also reported significant results, used a large, weekly dose of vitamin D, 60,000 IU
D3/week for the first 8 weeks followed by 60,000 IU/month for 4 months. The findings of these
studies contradict previous evidence that suggested larger weekly, monthly, or one‐off doses
of vitamin D are not as effective in producing an improvement in muscular strength. According
to Tomlinson et al. [202], the inconsistencies in the literature are partly the result of different
dosages of vitamin D and different treatment regimens.
16. Vitamin D levels, Athletes, and exercise performance
The first evidence regarding the possible association between vitamin D and performance
comes from early studies [41]. It have been reported that cardiovascular fitness, muscle
endurance, and speed were enhanced after exposure to ultraviolet radiation [41].
To date there is a growing number of evidence (Table 5) to support the association between
this secosteroid and exercise performance indices in athletic and physically active populations.
A recent study from our laboratory [28] reported a linear relationship between vitamin D levels
and muscle strength as evaluated by squat jump (SJ) and countermovement jump (CMJ),
sprinting ability (10 m and 20 m), and VO2max in non‐supplemented professional soccer players.
Our results are comparable with others showing that vitamin D levels are related with
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neuromuscular performance capacity and aerobic endurance in young physically active
individuals and athletes [202–205]. However, these findings are not universal. Others have
failed to find an association between exercise performance and vitamin D levels [206]. Vitamin
D status was not associated with grip strength or swimming performance in adolescent
swimmers [207] nor with isokinetic peak torque during knee flexion and extension after
adjusting for total body mass and lean mass in Qatar soccer players [208]. Hamilton et al. [208]
reported that vitamin D levels were not related with lower limb isokinetic muscle function in
soccer players. According to the authors, the lack of an association was most probably a result
of the different modes of exercise used in their study. They hypothesized that vitamin D could
preferentially affect muscle groups that were not evaluated in the study. In this study, soccer
players with vitamin D levels <50 nmol/L exhibited significantly lower torque in hamstring
and quadriceps muscle groups, suggesting that low vitamin D levels are associated with
impaired muscular function during exercise. However, no association was observed between
performance and vitamin D levels in hockey players [206]. Indeed, low explosive strength
during jumping was not associated with vitamin D levels neither status nor power production
during the Wingate anaerobic test [206].
Study No. of
participants
Sport Study loca-
tion/period
Parameters
measured
Results
Koundourakis
et al. [28]
67 male
professional
players, age 25.6
± 6.2 y
Soccer 6‐week off‐
season
transition
period, June–
July, 35.9°N
latitude
Squat jump (SJ),
countermovement jump
(CMJ), 10m sprint, 20 m
sprint, maximal oxygen
consumption (VO2max)
Significant associations
between vitamin D
levels and all the
measured performance
indices
Fitzgerald et al.
[206]
53 junior and
collegiate male ice
hockey players, age
20.1 ± 1.5 y
Hockey Off‐season
period, 44.9°N
latitude
Grip strength, Wingate
anaerobic test, squat jump
(SJ)
Significant associations
between vitamin D
levels and grip
strength, time to half
peak force but not
Wingate test and SJ
Forney et al.
[205]
39 males and
females, physically
active individuals,
age 23.26 ± 0.7 y
Various
types of
physical
activity
July and
September,
30.46°N
latitude
Maximal oxygen
consumption (VO2max),
Wingate test, vertical and
horizontal jump, sit and
reach test, maximum
muscle strength of bench
press, leg curl, leg extension,
upright row, bicep curl,
triceps pushdown
Significant positive
associations between
vitamin D levels and
VO2max, but not for any
measures of strength
and power
Dubnov‐Raz
et al. [207]
80 competitive
adolescent
swimmers from
both sexes, age 14
± 1.6 y
Swimming Israel, located
between
latitudes
32.40°N and
31.55°N
Grip strength, balance, and
swimming performance at
several speeds
No significant
associations between
vitamin D levels and
any measures of
performance
y, years
Table 5. Vitamin D levels and athletes.
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Regarding VO2max and aerobic capacity, evidence from large epidemiologic cross‐sectional
investigations indicate that 25(OH)D concentration is associated with cardiovascular fitness.
Mowry et al. [204] found a positive correlation between baseline cardiorespiratory fitness
VO2max and serum 25(OH)D levels in 16‐ to 24‐year‐old healthy women. Similarly, Ardestani
et al. [209] reported that there was evident a strong association between 25(OH)D levels and
VO2max in men and women (20–73 years old) over a broad range of 25(OH)D levels (10–82 ng/
mL). Interestingly, this correlation was also evident in subjects with low levels of physical
activity after adjusting for age, gender, BMI, and moderate to vigorous physical activity. Early
studies have shown that exposed to sun athletes showed improved aerobic fitness compared
to controls [28]. A recent study in professional soccer players reported that VO2max was
significantly related to vitamin D status [28]. Similar findings were reported in young physi‐
cally active individuals [205]. The authors also reported that the individuals who had 25OHD
levels above the recommended limit of 35 ng/mL, which was used as a cut‐off value indicating
vitamin D sufficiently in their study, were found to have significantly higher VO2max values
(20 %) than individuals below this cut‐off point. On the contrary, it was reported that vitamin
D status was not associated with neither the VO2peak, as a measure of cardiorespiratory fitness,
nor the end stage completed during a skating treadmill GXT in junior and collegiate male
hockey players [206]. The authors suggested that these findings could be the result of the fact
that none of their players were vitamin D deficient. According to Wilson et al. [210], worsening
in aerobic capacity could result only as in vitamin D‐deficient individuals. In the study by
Fitzgerald et al. [206], the authors reported that although 37.7 % of their athletes had insufficient
25(OH)D levels, levels at the deficiency range are necessary for a compromise of cardiovascular
fitness to ensue.
17. Vitamin D supplementation and athletes
Few published studies have reported that vitamin D supplementation benefits neuromuscular
and aerobic performance capacity (Table 6). Indeed, a randomized placebo‐controlled study
examined the effects of vitamin D3 supplementation (5000 IU per day) for 8 weeks on mus‐
culoskeletal performance [211] in highly trained male professional soccer players. Approxi‐
mately 62 % of the athletes on supplementation and 73 % of the controls exhibited serum total
25(OH)D < prior to treatment at 50 nmol/L. Vitamin D supplementation increased serum total
25(OH)D from a mean baseline of 29–103 nmol/L, whereas the placebo group showed no
significant change. The authors found that vitamin D supplementation increased 10 m sprint
time and vertical jump compared to the placebo group. Similar data were found in another
study where athletes living at northerly latitudes (the United Kingdom = 53°N) had low
vitamin D levels (<50 nmol/L). Additionally these data suggest that inadequate vitamin D
levels are detrimental to musculoskeletal performance in athletes, while supplementation may
increase both sprinting capacity and jumping ability of the soccer players. In support to these
findings, Wyon et al. [212] reported enhanced neuromuscular performance in a different type
of athletic population, i.e., in elite classical ballet dancers in a study which employed a 4‐month
oral supplementation of vitamin D3. Isometric muscular strength and vertical jump height
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were measured pre‐ and post intervention. A significant increase of isometric strength (18.7 
%) and vertical jump (7.1 %) was observed. The intervention group also sustained significantly
less injuries than the controls during the study period. In agreement with these data are the
findings of another study from the same group [213]. The authors examined the acute effects
of vitamin D supplementation on muscle function using isokinetic dynamometry. White adult
male national‐level judoka athletes who were involved in full‐time training participated in the
study and were randomly allocated to the treatment (150,000 IU vitamin D3) or placebo and
given blinded supplements by an independent researcher. Participants were tested twice, 8
days apart, on a Monday morning before the start of judo training and after 2 days of rest. A
5–7 mL of blood sample was collected followed by isokinetic concentric quadriceps and
hamstring. The treatment group had a significant increase in serum 25(OH)D3 levels (34 %)
and muscle strength (13 %). However, other studies were unable to document any benefit
following vitamin D supplementation in athletes with adequate or moderately deficient levels
of vitamin D prior to supplementation. Close et al. [214] examined the effects of vitamin D3
supplementation on serum 25[OH]D concentrations and on several exercise performance
indices in club‐level athletes. Participants were randomized into those receiving placebo,
20,000 or 40,000 IU per week of oral vitamin D3 for a 12‐week period. At baseline 57 % of the
participants were found to be almost vitamin D deficient (mean 51 nmol/L). In the two
supplementation groups, the following 6‐week and 12‐week period either with 20,000 IU
vitamin D levels increased to 79 and 85 nmol/l, respectively, or with 40,000 IU vitamin D3 to
98 and 91 nmol/l, respectively. Despite the different supplementation dosages, all individuals
managed to reach levels greater than the suggested deficiency limit of 50 nmol/l. However,
despite the observed increase in vitamin D serum levels, neither group exhibited an improve‐
ment of their exercise performance compared to controls [214]. The inability of the authors to
document any beneficial effect of vitamin D on athletic performance may be due the fact that
the participants of their study were not vitamin D deficient. It has been shown that the
beneficial effects of vitamin D supplementation take place in individuals with significant
vitamin D deficiency [158]. The lack of any beneficial effect of vitamin D supplementation was
also reported in another study involving football players [215]. A placebo group and one
receiving 5000 IU/day of vitamin D were examined. Both groups followed the same high‐
intensity training regime and had total work, sprint performance (5, 10, 20, 30 m), and jumping
ability (squat jump and countermovement jump) measured. No significant differences were
evident at baseline between the two groups for any of the measured parameters. The authors
reported that although all examined performance indices, apart from the 30 m sprint value,
were significantly higher as a result of the high‐intensity interval training regime, the mean
change scores (obtained values at the end of the study minus those of baseline) did not differ
significantly between the two groups, an outcome suggesting that vitamin D supplementation
did not had any beneficial effect. It should be noted here that the baseline vitamin D levels of
the majority soccer players in this study were deficient. Therefore the proposed mechanism
by Dahlquist et al. [158] was not applicable in this study. The authors suggest that other factors
apart of vitamin D levels play a pivotal role including their initial training status. It is true
though that the studies evaluating the effects of vitamin D supplementation on aerobic capacity
in athletes are few and between. Jastrzebski et al. [216] have examined the effects of vitamin
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D supplementation on VO2max. The treatment group was composed of 14 elite lightweight
rowers having sufficient 25(OH)D concentrations (>30 ng/mL). They were put under vitamin
D supplementation of 6000 IU per day for an 8‐week period. The authors found a significant
increase in VO2max following vitamin D supplementation. Thus, it was concluded that 8 weeks
of vitamin D supplementation during the training cycle of the same period of time resulted in
enhanced aerobic metabolism in this type of athletes. However, since this is the only study that
has examined vitamin D supplementation in athletes, these results cannot be generalized to
all sporting disciplines. Furthermore, the low sample size of the study is another limiting factor
regarding these findings.
Study Quality Sports Participants Intervention Parameters measured Results
Close et al.
[211]
Placebo‐
controlled
trial
Soccer 11 male soccer
players, age =
18 ± 5 y
8 weeks,
supplementation of
5000 IU/day of vitamin
D3 or a cellulose
placebo
1RM bench press and
back squat, 10 m and
30m sprint, Illinois
agility test, vertical
jump
Significant ↑ in
vertical jump
height, 10m sprint
times, and a trend
for ↑ bench press
and back squat
1RM
Wyon et al.
[212]
Controlled
trial
Ballet 24 elite male
and female
classical ballet
dancers, age 28
± 3.85 y
4‐month
supplementation of
vitamin D3 (2000 IU
per day)
Isometric muscular
strength and vertical
jump height
Significant ↑ in
isometric
muscular strength
and vertical jump
height
Wyon et al.
[213]
Randomized
controlled
double‐blind
trial
Judoka 22 white male
national‐level
judoka athletes.
27.5± 4 y
Acute effects, 1 week,
one single dose of 150
000 IU vitamin D3 or
placebo
Isokinetic concentric
quadriceps, hamstring
muscle strength
Significant ↑ in all
measured
strength‐related
indices
Close et al.
[214]
Randomized
controlled
trial
Various
sports
30 club‐level
athletes
Three groups receiving
a placebo (PLB) either
20,000 or 40,000 IU/
week of oral vitamin
D3 for 12 weeks
RM bench press, leg
press, vertical jump
height
Neither dose
given for 12
weeks improved
the examined
measures of
physical
performance
Jastrzebski,
[216]
Randomized
controlled
trial
Rowing 14 elite
lightweight
rowers
8 weeks of 6000 IU/day
of vitamin D3 in
sufficient athletes
(>30 ng/mL)
Maximal oxygen
consumption (VO2max)
Significant ↑ in
VO2max
Jastrzębska
et al. [215]
Controlled
trial
Soccer 36 young soccer
players, age:
17.5 ± 0.6 y
Treatment: around
5000 IU/day
placebo— sunflower
oil
Wingate test. 5, 10, 20,
and 30 m sprint, squat
jump (SJ),
countermovement
jump (CMJ)
No significant
difference in any
of the measured
exercise
performance
parameters
y, years; ↑, increase
Table 6. Vitamin D supplementation and athletes.
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18. Conclusion
This chapter describes the role of vitamin D in athletic performance. It describes the effect of
vitamin D in several systems involved in exercise performance and physical activity in both
athletes and non‐athletes.
Vitamin D undoubtedly has a key role in the osseous health of both athletes and non‐athletes.
A growing body of evidence suggests that vitamin D is strongly related with the cardiovas‐
cular, immune, and neuromuscular systems. It is now clear that vitamin D plays an important
role in the ability to perform efficiently during the normal daily activities, while its deficiency
may result in poorer exercise performance. It should be mentioned that the vast majority form
the evidence regarding vitamin D and exercise come from non‐athletes. A growing number of
studies have suggested that vitamin D exerts a beneficial effect on exercise performance,
particularly in older adults and those with lower levels of circulating vitamin D. Regarding
the optimum levels of vitamin D, the current evidence suggests that value levels above 30 ng/
mL are needed. The majority of the vitamin D supplementation studies indicate that it may
beneficially affect physical activity, frailty, muscular tone, stability, mobility in the elderly, and
performance in physically active individuals or athletes only when pretreatment levels are
within the insufficiency range (<30 ng/ml). Specifically for athletes, although the results of
performance trials are not yet convincing enough to support vitamin D as a direct performance
enhancer, obtaining optimal 25(OH)D levels can reduce the risk of debilitating musculoskeletal
injury, and due to the active role in muscle, resolution of vitamin D insufficiency has the
potential to impact performance.
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